Gilead Sciences Inc (CHIX:GISd) Stock News, Headlines & Updates
Gilead Sciences Inc Stock News from GuruFocus
- 1
- 2
- 3
- 4
Jul 12, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
PRNewswire • 10:00am
Jul 11, 2025
Gilead Sciences (GILD) Q2 Earnings to Take a Hit from Development Charges
GuruFocus News • 5:55pm
Gilead (GILD) Projects $61M IPR&D Expenses Impact in Q2 2025 Earnings | GILD Stock News
GuruFocus News • 4:30pm
Gilead Sciences Inc (GILD) Trading Down 3.5% on Jul 11
GuruFocus News • 12:03pm
Jul 10, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
Marketwired • 9:00am
Jul 09, 2025
Gilead Sciences (GILD) Boosts Global Access to HIV Therapy Lenacapavir
GuruFocus News • 10:58am
Gilead Sciences Partners with Global Fund to Expand HIV Prevention Access | GILD stock news
GuruFocus News • 9:02am
Gilead Finalizes Agreement With the Global Fund to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries
Business Wire • 8:00am
Gilead Finalizes Agreement With the Global Fund to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries | G
GuruFocus News • 7:21am
Gilead (GILD) Partners with Global Fund to Enhance HIV Prevention | GILD Stock News
GuruFocus News • 7:16am
Jul 07, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
PRNewswire • 4:00pm
Jul 06, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
Marketwired • 9:00am
Jul 02, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
PRNewswire • 10:00am
Insider Sell: Daniel O'Day Sells 10,000 Shares of Gilead Sciences Inc (GILD)
GuruFocus News • 7:01pm
Jul 01, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
Marketwired • 9:00am
Jun 28, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
Marketwired • 9:00am
Jun 27, 2025
Gilead Sciences (GILD) Sees Boost as Supreme Court Upholds Obamacare Provision
GuruFocus News • 11:57am
Gilead (GILD) Receives Positive Outlook Following Supreme Court Decision | GILD Stock News
GuruFocus News • 11:45am
Jefferies Sees Positive Outlook for Gilead (GILD) After Court Ruling | GILD Stock News
GuruFocus News • 10:45am
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
PRNewswire • 10:00am
Jun 25, 2025
Gilead (GILD) Sees Increased Bearish Options Activity | GILD Stock News
GuruFocus News • 10:15am
GILD Enters New Partnership with Kymera for CDK2 Degrader Development | GILD Stock News
GuruFocus News • 10:00am
Gilead Sciences and Kymera Therapeutics Announce Strategic Collaboration | GILD stock news
GuruFocus News • 7:07am
Gilead Sciences and Kymera Therapeutics Enter Into Exclusive Option and License Agreement to Develop Novel Oral Molecular Glue CDK2 Degraders
Business Wire • 7:00am
Gilead Sciences (GILD) Anticipates 2025 EPS Impact Due to Kymera Transaction | GILD Stock News
GuruFocus News • 6:46am
Gilead (GILD) Enters Agreement with Kymera to Enhance Cancer Treatment | GILD Stock News
GuruFocus News • 6:45am
Gilead (GILD) Enters Agreement with Kymera for Novel Cancer Treatment | GILD Stock News
GuruFocus News • 6:31am
Gilead Sciences and Kymera Therapeutics Enter Into Exclusive Option and License Agreement to Develop Novel Oral Molecular Glue CDK2 Degraders | GILD Stock News
GuruFocus News • 6:19am
Gilead (GILD) Faces Challenges Amid H.I.V. Research Setbacks | GILD Stock News
GuruFocus News • 5:50am
Gilead Sciences (GILD) Faces Challenges in HIV Treatment Progress | GILD Stock News
GuruFocus News • 5:45am
Jun 24, 2025
Gilead Sciences Inc (GILD) Highlights Inspiring Story of Living with HIV | GILD stock news
GuruFocus News • 11:08am
Gilead Sciences - Born With HIV in the 80s: Kim's Story of Growing Up as a Dandelion
ACCESSWIRE • 11:00am
Jun 23, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
Marketwired • 12:00pm
Jun 22, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
PRNewswire • 10:00am
Jun 20, 2025
Gilead (GILD) Gains Momentum with Latest HIV Prevention Approval | GILD Stock News
GuruFocus News • 5:00am
Jun 19, 2025
Gilead (GILD): Yeztugo's Future Amid Market Challenges | GILD Stock News
GuruFocus News • 6:00pm
Gilead (GILD) Gains Momentum with Yeztugo Approval | GILD Stock News
GuruFocus News • 7:15am
Jun 18, 2025
Gilead's (GILD) HIV Treatment Yeztugo Gains FDA Approval, Market Potential Expands | GILD Stock News
GuruFocus News • 3:15pm
FDA Approval Boosts Gilead's (GILD) Prospects in HIV Prevention | GILD Stock News
GuruFocus News • 3:15pm
Gilead Sciences (GILD) Gains FDA Nod for HIV Prevention Drug
GuruFocus News • 2:56pm
- 1
- 2
- 3
- 4
Show
Entries
Headlines
Total 0- 1
No recent news